Elotuzumab Chemical Properties

storage temp. 

Store at -20°C

form 

Liquid

color 

Colorless to light yellow

Elotuzumab Usage And Synthesis

Uses

Elotuzumab is a monoclonal antibody directed against the SLAMF7 receptor. Elotuzumab has no significant antimyeloma activity when given as a single agent with relapsed or refractory multiple myeloma (RRMM). Elotuzumab results in improved response and outcome when combined with other antimyeloma agents[1].

References

[1] Magen H, et al. Elotuzumab: the first approved monoclonal antibody for multiple myeloma treatment. Ther Adv Hematol. 2016;7(4):187-195.

Elotuzumab(915296-00-3)Related Product Information

• Uliledlimab
• Bavituximab
• Lucatumumab
• Fasinumab
• Sutimlimab
• Cofetuzumab
• Urtoxazumab
• Simtuzumab
• Aprutumab
• Cusatuzumab